Tracer library / Cu-PTSM

Cu-PTSM

Also written as Cu-PTSM; copper pyruvaldehyde bis(N4-methylthiosemicarbazone)
Radionuclide
Modality
—
Production route
—
Stage
Clinical research
Syntheses indexed
0
Myocardial perfusionCerebrovascular disease / cerebral perfusion imaging

What it is

Compound class
Copper(II) bis(thiosemicarbazone) complex
Target / mechanism
—
Clinical application
Cerebral, myocardial and renal blood flow imaging with PET/SPECT PMID 2308007
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Clinical literature

Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.

  1. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
    2000 · J Nucl Med · Clinical study

Need this precursor?We can point you to suppliers for Cu-PTSM, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 5 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 2308007, 2342070, 2394015, 8455082, 10688116. Stage set/updated at stage 39 from PMID 10688116: 'A total of 34 generators have been produced and shipped to 2 clinical sites for a phase III Food and Drug Administration study.'.